Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| CYCLOPHOSPHAMIDE FOR INJECTION USP | Sterimax Inc | Marketed | Sep 27, 2024 | Marketed |
| PMS-PALBOCICLIB | Pharmascience Inc | Marketed | Sep 27, 2024 | Marketed |
| JAMP CEFUROXIME | Jamp Pharma Corporation | Marketed | Sep 27, 2024 | Marketed |
| CYCLOPHOSPHAMIDE FOR INJECTION USP | Sterimax Inc | Marketed | Sep 27, 2024 | Marketed |
| HEPARIN SODIUM INJECTION USP | Sterimax Inc | Marketed | Sep 26, 2024 | Marketed |
| VIAGRA | BGP Pharma ULC | Marketed | Sep 26, 2024 | Marketed |
| NALOXONE HYDROCHLORIDE INJECTION USP | sterinova inc. | Marketed | Sep 26, 2024 | Marketed |
| PEROXIDE CLEANER DISINFECTANT | PROJECT CLEAN INC | Marketed | Sep 25, 2024 | Marketed |
| XOLAIR | novartis pharmaceuticals canada inc | Marketed | Sep 25, 2024 | Marketed |
| XOLAIR | novartis pharmaceuticals canada inc | Marketed | Sep 25, 2024 | Marketed |
| TEVA-SITAGLIPTIN MALATE / METFORMIN | teva canada limited | Marketed | Sep 24, 2024 | Marketed |
| TEVA-SITAGLIPTIN MALATE / METFORMIN | teva canada limited | Marketed | Sep 24, 2024 | Marketed |
| AMB-BUSPIRONE | ambicare pharmaceuticals inc. | Marketed | Sep 24, 2024 | Marketed |
| TEVA-SITAGLIPTIN MALATE / METFORMIN | teva canada limited | Marketed | Sep 24, 2024 | Marketed |
| INTRA MULTI-DES GA | INTRACARE BV | Marketed | Sep 23, 2024 | Marketed |
| NRA-LURASIDONE | nora pharma inc | Marketed | Sep 23, 2024 | Marketed |
| NRA-LURASIDONE | nora pharma inc | Marketed | Sep 23, 2024 | Marketed |
| NRA-LURASIDONE | nora pharma inc | Marketed | Sep 23, 2024 | Marketed |
| SANDOZ LISDEXAMFETAMINE CAPSULES | Sandoz Canada, Inc. | Marketed | Sep 23, 2024 | Marketed |
| NRA-LURASIDONE | nora pharma inc | Marketed | Sep 23, 2024 | Marketed |
